Replies to post #17951 on Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

yes runncoach, I know you are one of the few people here who truly understand this company.

My take on the positive posts in February:

1. SRL hype caused high volume starting on Feb. 1st, resulting in a lot of RXPC shares in new hands the first week of February.

2. That volume allowed the lenders to convert a large portion of the remaining A/S.

3. The new group of RXPC shareholders bought solely on the volume without doing DD - a strategy that often works in the pinksheets. In this case, the volume dried up quickly, and they started doing a little DD. They didn't like what they found.

4. Result: there were lots of posts on this message board in february that were very, very positive... from shareholders who wanted to sell.

I am looking for a bankruptcy 8-K before the jury trial in November. If I am right about that, I don't expect it on November 11th... I expect it in September. I think MacLellan is waiting for Gartner to get funding so they can sign a license agreement with a bankruptcy clause similar to the UNI agreement, but, I don't think MacLellan will wait much longer.

This is still the best story on wall street! But I think we finally get closure in the next 30 days.